Lupin Launches First Generic Xarelto in US Market Despite Ongoing Patent Litigation
Lupin has begun rolling out the first generic version of the blockbuster anticoagulant Xarelto (rivaroxaban) in the US market after the Patent Trial and Appeal Board invalidated a key patent.
© Copyright 2025. All Rights Reserved by MedPath